Pharmafile Logo
Pharmafocus logo
Advanced Search
scripps_research_web_03-18-19_t670

Scripps Research and IAVI report positive findings from HIV vaccine Phase I trial

February 4, 2021
HIV

Scripps Research and IAVI have returned positive Phase I results in their hunt for a HIV vaccine, detecting a targeted …

News
astrazeneca-sign

China approves AstraZeneca’s heart failure drug Forxiga

February 4, 2021
AstraZeneca, Forxiga

AstraZeneca’s Forxiga (dapagliflozin) has been approved for use in China to reduce the risk of death and hospitalisation from heart …

News
caroline_oconnor

Raremark appoints Caroline O’Connor as CCO

February 4, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Raremark has appointed Caroline O’Connor as its new Chief Commercial Officer. Previously holding the position of Raremark’s Senior Vice President …

Appointment

Pfizer and Imcyse enter research and licence agreement for rheumatoid arthritis programme

February 4, 2021
Imcyse, Pfizer

Imcyse has entered into a research collaboration and licence agreement with Pfizer for Imcyse’s rheumatoid arthritis (RA) programme based on …

News

NICE recommends MSD’s Keytruda in combination with chemotherapy for lung cancer

February 4, 2021
Cancer, MSD

NICE has recommended MSD’s Keytruda (pembrolizumab) with pemetrexed and platinum chemotherapy (pembrolizumab combination) as a first-line option for untreated, metastatic, …

News
jazz_pharma

Jazz acquires GW Pharmaceuticals in $7.2 billion deal

February 4, 2021
cannabinoid, jazz pharmaceuticals

Jazz Pharmaceuticals has acquired GW Pharmaceuticals for over $7 billion, with the transition expected to close in the second quarter …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

February 3, 2021
Research and Development COVID-19

The past week has seen mostly positive COVID-19 vaccine developments; Pfizer has confirmed its jab is effective against both the …

News
astrazeneca_sign_sky

Longer Oxford-AstraZeneca vaccine interval improves efficacy, report says

February 3, 2021
Research and Development AstraZeneca, COVID-19

A longer interval between doses of the Oxford University-AstraZeneca vaccine could substantially improve efficacy, according to a report published in …

News

GSK and CureVac sign £132m deal to develop next-generation COVID-19 vaccine

February 3, 2021
Research and Development COVID-19, CureVac, GlaxoSmithKline

GlaxoSmithKline (GSK) and CureVac have today announced they are joining forces to develop a new COVID-19 vaccine to combat future …

News
stock-incyte-01-shutter

CHMP recommends marketing authorisation for Incyte’s pemigatinib

February 3, 2021
Research and Development EMA, Incyte

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the conditional marketing authorisation of Incyte’s pemigatinib for …

News

New urine test could detect womb cancer in three hours

February 3, 2021
Research and Development Cancer, urine test

A simple test using patented technology to detect the cancer biomarker MCM5 (Minichromosome Maintenance Complex Component 5) in urine could …

News
philippe_dro

Scenic Biotech appoints Dr Philippe Dro as Chairman

February 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Scenic Biotech has announced the appointment of Dr Philippe Dro as its independent Chairman. Dr Dro replaces Dr Ulrich Grau, …

Appointment

Chelsea & Westminster Hospital launches diabetes care app

February 2, 2021
Manufacturing and Production

Chelsea and Westminster Hospital NHS Foundation Trust have today announced the use of a new app designed to revolutionise diabetes …

News
dw-anzcxqaqavhl

FDA approves new IM administration route for Biogen’s MS drug Plegridy

February 2, 2021
Manufacturing and Production Biogen, MS

The FDA has approved a new intramuscular (IM) injection route of administration for Biogen’s Plegridy (peginterferon beta-1a) for the treatment …

News
merckincweb

Combination of Keytruda and Yervoy does not improve cancer survival, MSD trial finds

February 2, 2021
Manufacturing and Production Cancer, MSD

A new trial by Merck – known as MSD outside of North America – has found that their lung cancer …

News

EMA recommends Arvelle’s seizure drug cenobamate

February 2, 2021
Manufacturing and Production Arvelle Therapeutics, epilepsy

The EMA has recommended the approval of Arvelle Therapeutics’ cenobamate for the adjunctive treatment of focal onset seizures with or …

News
gocovri

Adamas’ Parkinson’s drug gets US marketing authorisation for second indication

February 2, 2021
Manufacturing and Production Adamas Pharmaceuticals, FDA

The FDA has granted marketing authorisation for a second indication for Adamas Pharmaceuticals’ Gocovri (amantadine) extended release capsules. The drug …

News

EMA grants marketing authorisation for Amarin’s heart attack treatment

February 1, 2021
Sales and Marketing Amarin, EMA

Amarin have been granted authorisation from the EMA to market a treatment that will reduce the chance of heart attacks …

News

Johnson & Johnson’s single-shot COVID-19 vaccine 85% effective

February 1, 2021
Sales and Marketing COVID-19, Johnson & Johnson, vaccines

Johnson & Johnson has announced that its COVID-19 vaccine candidate is 85% effective in preventing serious symptoms of the disease, …

News
xarelto_10_tablet1

Bayer’s venous thromboembolism drug Xarelto gets UK approval for children

February 1, 2021
Sales and Marketing Bayer

Bayer has received UK approval for the use of its oral Factor Xa inhibitor Xarelto (rivaroxaban) to treat venous thromboembolism …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026